Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20873230 | 0.87 | TDP1 (0.44) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL19251642 | 0.85 | CYP3A4 (0.42) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL20697881 | 0.85 | TRPA1 (0.45) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL23182095 | 0.85 | CYP3A4 (0.42) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL28294523 | 0.83 | CYP3A4 (0.41) | TDP1CYP3A4TSHRESR2CYP2A6 | |
| SCHEMBL21331888 | 0.82 | CYP3A4 (0.44) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL20697880 | 0.82 | CA1 (0.43) | TDP1CYP3A4TSHRCYP1A2ALDH1A1 | |
| SCHEMBL3665710 | 0.82 | TDP1 (0.39) | TDP1CYP3A4ACHETSHRESR1 | |
| O-Xylene SCHEMBL5617302 | 0.81 | CYP3A4 (0.71) | TDP1CYP3A4ACHETSHRESR1 | |
| SCHEMBL7999830 | 0.81 | TDP1 (0.48) | TDP1CYP3A4ACHETSHRESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | claimed |
| CN-108779041-B | Ruthenium and osmium dicarbonyl catalysts | 乌迪内大学 | 2022-05-13 | — | — | CN | claimed |
| EP-3411346-B1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-04-28 | — | — | EP | claimed |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2021-04-15 | — | — | US | claimed |
| EP-3411346-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | Universita' Degli Studi di Udine (IT) | 2018-12-12 | — | — | EP | claimed |
| WO-2017134620-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | claimed |
| US-11819837-B2 | Monocarbonyl ruthenium and osmium catalysts | UNIVERSITA DEGLI STUDI DI (IT) | 2023-11-21 | — | — | US | disclosed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | disclosed |
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | Universita′ degli Studi di Udine (IT) | 2023-06-27 | — | — | US | disclosed |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2023-05-11 | — | — | US | disclosed |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2023-05-11 | — | — | US | disclosed |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | Universita' Delgi Studi Di Udine (IT) | 2023-02-14 | — | — | US | disclosed |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | Universita' Delgi Studi Di Udine (IT) | 2023-02-14 | — | — | US | disclosed |
| US-8357799-B2 | Light emitting material | SOLVAY (SOCIETE ANONYME) (BE) | 2013-01-22 | — | — | US | disclosed |
| CN-102046642-A | Hydroformylation catalysts | EASTMAN CHEM CO | 2011-05-04 | — | — | CN | disclosed |
| EP-2155764-B1 | LIGHT EMITTING MATERIAL | SOLVAY (BE) | 2011-01-05 | — | — | EP | disclosed |
| CN-101808972-A | Carbonylation process for the production of acetic acid using metal-pincer ligand catalysts | BP CHEM INT LTD | 2010-08-18 | — | — | CN | disclosed |
| US-20100190984-A1 | Light emitting material | SOLVAY (SOCIETE ANONYME) (BE) | 2010-07-29 | — | — | US | disclosed |
| EP-2155764-A1 | LIGHT EMITTING MATERIAL | SOLVAY (Société Anonyme) (BE) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008148829-A1 | LIGHT EMITTING MATERIAL | Solvay (Société Anonyme) (BE) | 2008-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685755-B2 | Dicarbonyl ruthenium and osmium catalysts | OTC, ODC1, CBR3 | TDP1 908/4885CYP3A4 2997/4885ACHE 2357/4885 |
| US-20230145668-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, CBR3, IDH2 | TDP1 3573/4885CYP3A4 2612/4885ACHE 2952/4885 |
| US-11819837-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | TDP1 3573/4885CYP3A4 2612/4885ACHE 2952/4885 |
| US-20100190984-A1 | Light emitting material | PPOX, CRY2, PIN4 | TDP1 4501/4885CYP3A4 1580/4885ACHE 473/4885 |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, ODC1, CBR3 | TDP1 908/4885CYP3A4 2997/4885ACHE 2357/4885 |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | TDP1 3573/4885CYP3A4 2612/4885ACHE 2952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.